Literature DB >> 10595833

Prevalence of subclinical hypothyroidism in a population living in the Milan metropolitan area.

G Rivolta1, R Cerutti, R Colombo, G Miano, P Dionisio, E Grossi.   

Abstract

Subclinical hypothyroidism is a condition characterized by increased levels of thyroid-stimulating hormone (TSH) associated with normal levels of free triiodothyronine (FT3) and free thyroxine (FT4). The exact prevalence of this condition in Italy is not known. The aim of this study was to assess the presence of subclinical hypothyroidism in 1001 subjects living in the Milan area (age 17-89) and apparently free from thyroid pathology. This sample which had applied to a large laboratory centre (Centro Diagnostico Italiano, Milano) for a routine check-up was seen from April to July 1996. A serum TSH assay was performed using a highly sensitive immunoenzymatic method, while an FT3 and FT4 assay was performed by means of a radioimmunologic method using commercial kits. The prevalence of subclinical hypothyroidism in the total population proved to be 4.7% (95% CI-Confidence Interval: 3.4-6.0). Sex stratification showed a prevalence of 6.1% in females and 3.4% in males. Prevalence in patients up to 65 was 4.2%. This value increased up to 8.0% in subjects over 65. By combining these variables, in females >65 prevalence increased to 11.3%. Overall, symptoms typical of overt hypothyroidism were found in 58.3% of patients suffering from subclinical hypothyroidism and in 39.9% of healthy subjects (p<0.02). The results of this study show that there is a significant presence (about 5%) of subclinical hypothyroidism in this population and that its frequency is more than doubled in women over 65. Early treatment might reduce the progression to overt hypothyroidism. The benefits of such a procedure were recently suggested by a decision making modelling approach applied to the Italian environment.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10595833     DOI: 10.1007/BF03343631

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  24 in total

1.  Clinical and biochemical features of muscle dysfunction in subclinical hypothyroidism.

Authors:  F Monzani; N Caraccio; G Siciliano; L Manca; L Murri; E Ferrannini
Journal:  J Clin Endocrinol Metab       Date:  1997-10       Impact factor: 5.958

2.  Does treatment with L-thyroxine influence health status in middle-aged and older adults with subclinical hypothyroidism?

Authors:  R Jaeschke; G Guyatt; H Gerstein; C Patterson; W Molloy; D Cook; S Harper; L Griffith; R Carbotte
Journal:  J Gen Intern Med       Date:  1996-12       Impact factor: 5.128

3.  Thyroid dysfunction in the elderly.

Authors:  G M Muller; N S Levitt; S J Louw
Journal:  S Afr Med J       Date:  1997-09

4.  Spectrum of subclinical and overt hypothyroidism: effect on thyrotropin, prolactin, and thyroid reserve, and metabolic impact on peripheral target tissues.

Authors:  J J Staub; B U Althaus; H Engler; A S Ryff; P Trabucco; K Marquardt; D Burckhardt; J Girard; B D Weintraub
Journal:  Am J Med       Date:  1992-06       Impact factor: 4.965

5.  L-Thyroxine therapy in subclinical hypothyroidism. A double-blind, placebo-controlled trial.

Authors:  D S Cooper; R Halpern; L C Wood; A A Levin; E C Ridgway
Journal:  Ann Intern Med       Date:  1984-07       Impact factor: 25.391

6.  Thyroid failure in the elderly. Microsomal antibodies as discriminant for therapy.

Authors:  M J Rosenthal; W C Hunt; P J Garry; J S Goodwin
Journal:  JAMA       Date:  1987-07-10       Impact factor: 56.272

7.  The prevalence of subclinical hypothyroidism in adults with low-normal blood thyroxine levels.

Authors:  M J Miller; C Pan; U S Barzel
Journal:  N Y State J Med       Date:  1990-11

8.  Disturbed lipid metabolism in patients with subclinical hypothyroidism: effect of L-thyroxine therapy.

Authors:  S Miura; M Iitaka; H Yoshimura; S Kitahama; N Fukasawa; Y Kawakami; S Sakurai; M Urabe; Y Sakatsume; K Ito
Journal:  Intern Med       Date:  1994-07       Impact factor: 1.271

9.  Thyroid disorders in the general population of Hisayama Japan, with special reference to prevalence and sex differences.

Authors:  K Okamura; T Nakashima; K Ueda; K Inoue; T Omae; M Fujishima
Journal:  Int J Epidemiol       Date:  1987-12       Impact factor: 7.196

10.  Clinical significance of mildly elevated thyrotropin levels with normal thyroxine levels.

Authors:  C A Brown; J V Hennessey
Journal:  South Med J       Date:  1989-06       Impact factor: 0.954

View more
  4 in total

1.  Hyperprolactinemia in association with subclinical hypothyroidism.

Authors:  Adele Bahar; Ozra Akha; Zahra Kashi; Zakiie Vesgari
Journal:  Caspian J Intern Med       Date:  2011

Review 2.  Subclinical hypothyroidism, mood, and cognition in older adults: a review.

Authors:  Russell T Joffe; Elizabeth N Pearce; James V Hennessey; Joseph J Ryan; Robert A Stern
Journal:  Int J Geriatr Psychiatry       Date:  2012-03-13       Impact factor: 3.485

Review 3.  Subclinical Hypothyroidism and Type 2 Diabetes: A Systematic Review and Meta-Analysis.

Authors:  Cheng Han; Xue He; Xinghai Xia; Yongze Li; Xiaoguang Shi; Zhongyan Shan; Weiping Teng
Journal:  PLoS One       Date:  2015-08-13       Impact factor: 3.240

Review 4.  Cardiovascular risk and quality of life in elderly people with mild thyroid hormone deficiency.

Authors:  Sara Tognini; Giuseppe Pasqualetti; Valeria Calsolaro; Antonio Polini; Nadia Caraccio; Fabio Monzani
Journal:  Front Endocrinol (Lausanne)       Date:  2014-10-07       Impact factor: 5.555

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.